Founded in Shanghai in 2010, Quan Capital invests in innovative early and growth stage life sciences companies, primarily in therapeutics and related areas, including enabling technologies and high-end services. Their unique investment philosophy allows them to explore disruptive solutions to critical healthcare problems impacting millions of lives. The firm's portfolio companies are pioneers in breakthrough therapies and cutting-edge technologies that generate significant value for patients. Quan Capital also invests in leading players that fulfill the rapidly growing needs of China's nascent innovation-driven ecosystem. With a team of seasoned investment professionals with a strong track record of high returns, Quan leverages its expertise in cross-border value creation with strong local execution capabilities, thanks to its presence in both China and the US.